Products

What will AGI do for Alminoprofen?

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C13H17NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0255AHR9GJ, chemically known as propionic acid, 2-(4-(methallylamino)phenyl)- but generally known as alminoprofen, which bears US NIH Compound Identifier 2097. European Medicines Agency schedules Alminoprofen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05347MIG. The term ALMINOPROFEN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 33, No. 10 1979, List 19). World Health Organization schedules alminoprofen in its Anatomical Therapeutic Chemical (ATC) Classification. ALMINOPROFEN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule alminoprofen under HS 29224995 and SITC 51465. As of Q4 2014, ALMINOPROFEN remains the US FDA Preferred Term for this commodity. Alminoprofen bears US NLM identifiers UMLS ID C0051247 and NCI Concept Code C73070. SMILES: OC(=O)C(C1CCC(NCC(=C)C)CC1)C.

How AGI delivers it

Four ways AGI delivers for Alminoprofen

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Alminoprofen, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Alminoprofen, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Alminoprofen connects

measured by

  • Active Ingredient Potencymodel
  • Assay Puritymodel
  • Chromatographic Impurity Profilemodel
  • Compound Puritymodel
  • Loss On Dryingmodel
  • Residual Solventmodel